Key Points
- Three terminally ill patients who took an experimental cancer vaccine were put into remission within months
- The vaccine teaches patients’ T cells to recognize their cancerous tumors around the body and attack them
- One patient was told that she would likely die within the next three years — before the vaccine saved her life
Read the full article
ThinkCivics researches, examines, and reports on issues that matter most. We deliver explanative, fearless, and insightful analysis for public consumption.
